OPK (OPKO Health) Notes Receivable : $0.0 Mil (As of Dec. 2024)

View and export this data going back to 1995. Start your Free Trial

What is OPKO Health Notes Receivable?

OPKO Health's Notes Receivable for the quarter that ended in Dec. 2024 was $0.0 Mil.

OPKO Health Notes Receivable Historical Data

The historical data trend for OPKO Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Notes Receivable Chart

OPKO Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Notes Receivable

Get a 7-Day Free Trial

OPKO Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

OPKO Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

OPKO Health Notes Receivable Related Terms

Thank you for viewing the detailed overview of OPKO Health's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

OPKO Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

OPK:Mexico OPK:Israel 0KCS:UK XCY:Germany

Address

4400 Biscayne Boulevard, Miami, FL, USA, 33137

Website

https://www.opko.com

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Executives

Frost Phillip Md Et Al	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Richard M Krasno	director	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 31337
Hsiao Jane Ph D	director	4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel	director, officer: Chief Innovation Officer	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni	director, officer: Vice Chairman and President	2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli	director, other: Chairman of the Board	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin	director	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy	director	C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen	director, officer: SVP OPKO; Exec Chairman BRLI	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez	officer: CAO, Treasurer	C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour	director	19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel	director	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137